These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 32535924)
21. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial. Visser J; Ulander VM; Helmerhorst FM; Lampinen K; Morin-Papunen L; Bloemenkamp KW; Kaaja RJ Thromb Haemost; 2011 Feb; 105(2):295-301. PubMed ID: 21103659 [TBL] [Abstract][Full Text] [Related]
22. Combined oral prednisolone and heparin versus heparin: the effect on peripheral NK cells and clinical outcome in patients with unexplained recurrent miscarriage. A double-blind placebo randomized controlled trial. Gomaa MF; Elkholy AG; El-Said MM; Abdel-Salam NE Arch Gynecol Obstet; 2014 Oct; 290(4):757-62. PubMed ID: 24818590 [TBL] [Abstract][Full Text] [Related]
23. Antithrombotic therapy to prevent recurrent pregnancy loss in antiphospholipid syndrome-What is the evidence? Hamulyák EN; Scheres LJJ; Goddijn M; Middeldorp S J Thromb Haemost; 2021 May; 19(5):1174-1185. PubMed ID: 33687789 [TBL] [Abstract][Full Text] [Related]
24. Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population. Franklin RD; Kutteh WH Hum Reprod; 2002 Nov; 17(11):2981-5. PubMed ID: 12407061 [TBL] [Abstract][Full Text] [Related]
25. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Triolo G; Ferrante A; Ciccia F; Accardo-Palumbo A; Perino A; Castelli A; Giarratano A; Licata G Arthritis Rheum; 2003 Mar; 48(3):728-31. PubMed ID: 12632426 [TBL] [Abstract][Full Text] [Related]
26. Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT. van Hoorn ME; Hague WM; van Pampus MG; Bezemer D; de Vries JI; Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():168-73. PubMed ID: 26771908 [TBL] [Abstract][Full Text] [Related]
28. [Diagnosis and treatment of antiphospholipid antibody-related recurrent spontaneous abortion and analysis of therapeutic drugs and pregnancy outcome in 75 patients with antiphospholipid syndrome]. Li XY; Zhao JX; Liu XY Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):956-961. PubMed ID: 30562764 [TBL] [Abstract][Full Text] [Related]
29. Antithrombotic therapy for pregnancy loss. de Jong PG; Goddijn M; Middeldorp S Hum Reprod Update; 2013; 19(6):656-73. PubMed ID: 23766357 [TBL] [Abstract][Full Text] [Related]
30. Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation. Karadağ C; Akar B; Gönenç G; Aslancan R; Yılmaz N; Çalışkan E J Matern Fetal Neonatal Med; 2020 Jun; 33(11):1934-1939. PubMed ID: 31550962 [No Abstract] [Full Text] [Related]
31. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Kutteh WH Am J Obstet Gynecol; 1996 May; 174(5):1584-9. PubMed ID: 9065133 [TBL] [Abstract][Full Text] [Related]
32. The role of prophylactic use of low dose aspirin and calheparin in patients with unexplained recurrent abortion. Maged AM; Abdelhafiz A; Mostafa WA; El-Nassery N; Fouad M; Salah E; Kotb A Gynecol Endocrinol; 2016 Dec; 32(12):970-972. PubMed ID: 27426855 [TBL] [Abstract][Full Text] [Related]
33. The Efficacy of Traditional Chinese Medicine Shoutai Pill Combined with Western Medicine in the First Trimester of Pregnancy in Women with Unexplained Recurrent Spontaneous Abortion: A Systematic Review and Meta-Analysis. Li HF; Shen QH; Li XQ; Feng ZF; Chen WM; Qian JH; Shen L; Yu LY; Yang Y Biomed Res Int; 2020; 2020():7495161. PubMed ID: 32851085 [TBL] [Abstract][Full Text] [Related]
34. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Farquharson RG; Quenby S; Greaves M Obstet Gynecol; 2002 Sep; 100(3):408-13. PubMed ID: 12220757 [TBL] [Abstract][Full Text] [Related]
35. Aspirin and heparin in the treatment of recurrent spontaneous abortion associated with antiphospholipid antibody syndrome: A systematic review and meta-analysis. Yu X; He L Exp Ther Med; 2021 Jan; 21(1):57. PubMed ID: 33365057 [TBL] [Abstract][Full Text] [Related]
36. Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis. Potdar N; Gelbaya TA; Konje JC; Nardo LG Hum Reprod Update; 2013; 19(6):674-84. PubMed ID: 23912476 [TBL] [Abstract][Full Text] [Related]
37. Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome. Fouda UM; Sayed AM; Abdou AM; Ramadan DI; Fouda IM; Zaki MM Int J Gynaecol Obstet; 2011 Mar; 112(3):211-5. PubMed ID: 21251653 [TBL] [Abstract][Full Text] [Related]
38. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. Laskin CA; Spitzer KA; Clark CA; Crowther MR; Ginsberg JS; Hawker GA; Kingdom JC; Barrett J; Gent M J Rheumatol; 2009 Feb; 36(2):279-87. PubMed ID: 19208560 [TBL] [Abstract][Full Text] [Related]
39. Does low-dose aspirin initiated before 11 weeks' gestation reduce the rate of preeclampsia? Chaemsaithong P; Cuenca-Gomez D; Plana MN; Gil MM; Poon LC Am J Obstet Gynecol; 2020 May; 222(5):437-450. PubMed ID: 31494125 [TBL] [Abstract][Full Text] [Related]
40. Antithrombotic Treatment for Recurrent Miscarriage: Bayesian Network Meta-Analysis and Systematic Review. Zhang T; Ye X; Zhu T; Xiao X; Liu Y; Wei X; Liu Y; Wu C; Guan R; Li X; Guo X; Hu H; He J Medicine (Baltimore); 2015 Nov; 94(45):e1732. PubMed ID: 26559249 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]